Higher TLR2 expression and a significantly increased response to TLR2 ligands have been observed in MS patients, suggesting a lack of regulation, a mechanism called TLR tolerance, which arises upon the repeated exposure to an adequate TLR2 stimulus. The gene discussed is TLR2; the disease is myeloid sarcoma.